Researchers compared survival outcomes in patients with stage III colon cancer randomized to receive either celecoxib or placebo for 3 years with chemo.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/celecoxib-benefit-seen-ctdna-positive-colon-cancer-2025a1000xzk?src=rss
Author :
Publish date : 2025-12-04 16:05:00
Copyright for syndicated content belongs to the linked Source.
